Pantazol 40 mg 14 tablets
Sovalue Pharma
Sovalue Pharma
Composition
Pantoprazole — 40 mg
Pharmacological action
Suppresses the activity of H⁺/K⁺-ATPase in the parietal cells of the stomach
Reduces both basal and stimulated secretion of hydrochloric acid
Facilitates the healing of ulcers and erosions
Indications for use
Gastroesophageal reflux disease (GERD)
Erosive esophagitis
Stomach and duodenal ulcers
Zollinger-Ellison syndrome
Prevention of ulcers caused by NSAIDs
As part of Helicobacter pylori eradication therapy (in combination with antibiotics)
Method of administration
Pantoprazole dosage for adults (depending on the condition)
Medical condition Dosage regimen pantoprazole
Gastroesophageal reflux disease (GERD) 40 mg orally once a day for 8–16 weeks, or 40 mg intravenously once a day for 7–10 days, then switch to tablets
Erosive esophagitis 40 mg orally once a day for 8–16 weeks, then maintenance dose of 40 mg per dayOr 40 mg intravenously once a day for 7–10 days, then switch to tablets
Zollinger-Ellison syndrome 40 mg orally once a day, as needed up to 240 mg/dayOr 80 mg intravenously every 8–12 hours for up to 7 days, then switch to tablets
Gastric ulcer (off-label) 40 mg orally once a day for 4 weeks
Duodenal ulcer (off-label) 40 mg orally once a day for 2 weeks
Dosage for children
Doses depending on the child’s age and body weight
Drug form Age Pantoprazole dosage Duration of treatment
Oral tablets 5 years and older 15–39 kg: 20 mg once daily≥40 kg: 40 mg once daily Up to 8 weeks
Intravenous administration 3–11 months <12.5 kg: 0.8 mg/kg once daily intravenously≥12.5 kg: 10 mg once daily intravenously Up to 7 days, then switch to tablets
1–17 years ≤15 kg: 10 mg once daily intravenously16–40 kg: 20 mg once daily intravenously>40 kg: 40 mg once daily intravenously —
Notes
After a course of intravenous administration, it is recommended to switch to the oral form in accordance with age and body weight.